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Introduction: Combined with massive lung aeration loss resulting from acute respiratory distress syndrome,
hepatopulmonary syndrome, a liver-induced vascular lung disorder characterized by diffuse or localized dilated
pulmonary capillaries, may induce hypoxaemia and death in patients with end-stage liver disease.
Methods: The case of such a patient presenting with both disorders and in whom an extracorporeal membrane
oxygenation was used is described.
Results: A 51-year-old man with a five-year history of alcoholic cirrhosis was admitted for acute respiratory failure,
platypnoea and severe hypoxaemia requiring emergency tracheal intubation. Following mechanical ventilation,
hypoxaemia remained refractory to positive end-expiratory pressure, 100% of inspired oxygen and inhaled nitric
oxide. Two-dimensional contrast-enhanced (agitated saline) transthoracic echocardiography disclosed a massive
right-to-left extracardiac shunt, without patent foramen ovale. Contrast computed tomography (CT) of the thorax
using quantitative analysis and colour encoding system established the diagnosis of acute respiratory distress
syndrome aggravated by hepatopulmonary syndrome. According to the severity of the respiratory condition, a
veno-venous extracorporeal membrane oxygenation was implemented and the patient was listed for emergency
liver transplantation. Orthotopic liver transplantation was performed at Day 13. At the end of the surgical
procedure, the improvement in oxygenation allowed removal of extracorporeal membrane oxygenation (Day 5).
The patient was discharged from hospital at Day 48. Three months after hospital discharge, the patient recovered a
correct physical autonomy status without supplemental O2.
Conclusions: In a cirrhotic patient, acute respiratory distress syndrome was aggravated by hepatopulmonary
syndrome causing life-threatening hypoxaemia not controlled by standard supportive measures. The use of
extracorporeal membrane oxygenation, by controlling gas exchange, allowed the performing of a successful liver
transplantation and final recovery.
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Introduction
Extracorporeal membrane oxygenation (ECMO) has the
capacity to support gas exchange as well as haemody-
namics and is, therefore, a rescue therapeutic option for
life-threatening respiratory and/or cardiac failure.
ECMO has been tested in acute respiratory distress syn-
drome (ARDS) [1,2] and before and after lung trans-
plantation [3]. Another potential use of ECMO could be
the management of life-threatening hypoxaemia in
patients with hepatopulmonary syndrome (HPS),
selected for orthotopic liver transplantation (OLT). HPS,
a liver-induced vascular lung disorder, is characterized
by diffuse or localized dilated pulmonary capillaries and,
less commonly, pleural and pulmonary arteriovenous
communications coexisting with normal alveolar ventila-
tion [4]. Hypoxaemia is usually responsive to oxygen
therapy [4], but OLT appears as the only successful
treatment [5,6]. However, in the most severe forms of
HPS (PaO2 < 50 mmHg on room air), OLT is associated
with increased respiratory morbidity/mortality due to
frequent post-operative worsening of hypoxaemia [5,7].
One case of successful use of ECMO in the manage-
ment of life-threatening hypoxaemia following OLT for
HPS has been reported [8] but there are no data con-
cerning its use in the pre-operative management.
Materials and methods
We here report the use of ECMO as a bridge to OLT in
a patient with refractory hypoxaemia resulting from
combined ARDS and HPS.
Results
Diagnosis of hepatopulmonary syndrome
A 51-year-old man was admitted to our institution for
haematemesis in a context of acute alcoholic intoxica-
tion. He had a five-year history of alcoholic cirrhosis
with several episodes of bleeding from œsophageal
varices and one episode of acute alcoholic hepatitis trea-
ted by corticosteroids. No hypoxaemia was detected
during his medical follow-up and successive hospitaliza-
tions. On admission (Day 1), he was in respiratory fail-
ure with platypnoea. His arterial oxygen saturation
(SaO2) before intubation was 87% at rest in a supine
position while breathing 15 L/minute oxygen (O2)v i aa
high concentration O2 face mask. Immediate tracheal
intubation and mechanical ventilation (MV) support
were required. On MV, pH, PaCO2 and PaO2,w e r e
7.29, 77 mmHg, and 58 mmHg, respectively, using 100%
O2, a tidal volume (TV) of 6 ml/kg of ideal body weight
and a positive end-expiratory pressure (PEEP) of 10
cmH2O. Inhaled nitric oxide at 40 parts per million did
not result in any improvement in gas exchange. Chest
radiograph demonstrated moderate bilateral pleural effu-
sion without clear evidence of alveolar consolidation and
the diagnosis of HPS was suspected. Two-dimensional
contrast-enhanced (agitated saline) transthoracic echo-
cardiography disclosed a hyperkinetic systolic profile
with low left ventricular filling pressures. The main
abnormality was a massive right-to-left extra-cardiac
shunt, without patent foramen ovale, confirming the
diagnosis of HPS.
Diagnosis of acute respiratory distress syndrome
Contrasting with bedside anterior chest radiography,
contrast computed tomography (CT) of the thorax
demonstrated bilateral consolidations of lower lobes with
dilated pulmonary vessels, moderate right pleural effu-
sion and no evidence of pulmonary embolism (Figure
1a). The diagnosis of focal ARDS was made according to
previously described criteria [9]. Secondary analysis of
CT sections with the colour encoding system of the soft-
ware Lungview
® (Institut National des Télécommunica-
tions, Evry, France) [10,11], confirmed the presence of
enlarged pulmonary vessels within consolidations, sus-
pected on mediastinal windows (Figure 1a). Quantitative
analysis of the whole lung according to a technique pre-
viously described [12], demons t r a t e da ni n c r e a s ei nl u n g
tissue (938 mL) predominating in the upper lobes (578
mL), a massive loss of lung aeration predominating in the
lower lobes (99 mL of gas) and the presence of hyperin-
flation of the upper lobes (463 mL), a pattern strongly
evocative of focal acute respiratory distress syndrome
[13]. Beside lung failure, the first 24 hours after admis-
sion were marked by the development of circulatory
shock requiring norepinephrine, acute renal failure and
acute liver failure with cell necrosis: aspartate amino
transferase (ASAT) = 1340 IU/L, alanine aminotransfer-
ase (ALAT) = 600 IU/L, alkaline phosphatase (AP) = 104
IU/L, gamma-glutamyl transpeptidase (g-GT) = 80 UI/L,
total bilirubin = 60 μmol/L, prothrombine time (PTT) =
40%, platelet count = 147 G/L. Despite the negativity of
all bacteriological samplings, an empiric broad-spectrum
antibiotic therapy was urgently started given the high
suspicion of pneumonia.
Extracorporeal membrane oxygenation
Over the next seven days, function of the involved
organs stabilized with the exception of the lung, gas
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mmHg, and PaO2: 51 mmHg under 100% FiO2).
According to the severity of the respiratory condition,
the French network for organ sharing national review
board was petitioned and the patient was listed for
transplantation with an urgent United Network for
Organ Sharing (UNOS) 1a status. Facing the life-threa-
tening hypoxaemia with failure of conventional ventila-
tory support to control gas exchange, even though he
was given a high priority status, the patient was consid-
ered to be a candidate for ECMO as a bridge to trans-
plantation. At Day 8, a veno-venous (V-V) ECMO was
percutaneously placed with a 24-French venous drainage
cannula in the right jugular vein, and a 19-French
venous return cannula in the right femoral vein.
According to previous recommendations demonstrating
the superiority of polymethylpentene oxygenators over
polypropylene oxygenators [14,15], the ECMO device
Figure 1 Chest CT performed on Day 3 and Day 37 after the onset of refractory hypoxaemia. a) Chest computed tomography (CT) on
Day 3 following the onset of refractory hypoxaemia showing a bilateral consolidation of lower lobes with a right pleural effusion extending to
the main fissura (upper CT section, parenchymal window). Large vessels are opacified within each lower lobe consolidation (middle CT section,
mediastinal window). The application of a colour encoding system (lower part of the figure) confirms the consolidation of lower lobes [red
colour, characterizing nonaerated lung regions with CT attenuations > -100 Hounsfield densities (HU)], shows the hypervascularization of lung
consolidations (black colour, characterizing pulmonary vessels containing contrast material with CT attenuations > +200 HU) and evidences the
hyperinflation of upper lobes (white colour, characterizing hyperinflated lung regions with CT attenuations < -900 HU). Normally (dark grey
colour, characterizing lung regions with CT attenuations ranging between -900 and -500 HU) and poorly aerated lung regions (light grey colour,
characterizing lung regions with CT attenuations ranging between -500 and -100 HU) are located to upper lobes. b) The same CT sections
obtained at Day 20 following liver transplantation (37 days after the onset of refractory hypoxaemia) showing a persisting consolidation of the
right lower lobe without pleural effusion. Large vessels are not anymore opacified within the consolidation (middle CT section, mediastinal
window). The application of the colour encoding system (lower part of the figure) confirms the consolidation, the presence of hyperinflated lung
regions in upper lobes. It does not show anymore hypervascularization within the right consolidation, suggesting a regression of HPS.
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tem, a Quadrox PLS 2050
® oxygenator (Maquet GmbH,
Rastatt, Germany), and a Rotaflow RF32
® centrifugal
pump (Maquet GmbH, Rastatt, Germany), a flow probe
and 3/8-in. internal diameter heparin-bound tubing.
Because of the heparin-bound tubing sets, systemic
administration of heparin was limited to an intravenous
bolus of 75 IU/kg before cannulation. Human albumin
(5%, 500 mL) with physiological saline (500 mL) supple-
mented with 1,000 IU of heparin was used as a priming
solution. Correct position of both cannulae was verified
by transœsophageal echocardiography. Under the
ECMO support, controlled MV using a constant inspira-
tory flow was used with a TV of 4 ml/kg, a respiratory
frequency of 22/minute, a PEEP of 10 cmH2O and FIO2
60%. The objective was to maintain ECMO flow above 3
to 4 L/minute without ever reducing it below 1 L/min-
ute to avoid the risk of cannula clotting.
Liver transplantation
The patient remained stable under ECMO support until
he underwent, after six days on a waiting list, uncompli-
cated OLT from a deceased donor on Day 13, (ECMO
Day 5). During that period, the platelet count remained
between 100 and 130 G/L. The procedure was per-
formed under V-V ECMO. It required seven units of
packed red blood cells, four units of fresh frozen plasma,
eight units of human albumin (4%, 500 mL), and one
liter of colloid. Cold and warm ischemic times were 400
minutes and 41 minutes, respectively. At the end of the
surgical procedure, the improvement in oxygenation
allowed removal of ECMO (Day 13). Despite an episode
of methicillin resistant Staphylococcus epidermidis venti-
lator-associated pneumonia treated intravenously by gly-
copeptids, nitric oxide could be stopped on Day 20. On
the same day, a CT of the chest demonstrated a marked
improvement as compared with the pre-operative CT.
As shown in Figure 1b, the left lower lobe was comple-
tely re-aerated whereas the right lower lobe appeared
atelectatic, free of enlarged pulmonary vessels. Quantita-
tive analysis of the whole lung revealed a decrease in
lung tissue (from 938 to 815 mL), a partial re-aeration
of the lower lobes (from 99 to 591 mL) and the persis-
t e n c eo fs o m ed e g r e eo fh y p e r i n f l a t i o ni nt h eu p p e r
lobes (from 463 to 213 mL). Transthoracic lung ultra-
sound revealed a limited hemi-diaphragm excursion,
suggesting post-surgical diaphragmatic dysfunction with
corresponding passive right lower lobe atelectasis. On
Day 27, the patient’s trachea was successfully extubated.
Beside lung function improvement, liver function also
improved from Day 18 with normalization of liver
enzymes and coagulation factors. On Day 30, laboratory
parameters showed ASAT = 33 IU/L, ALAT = 42 IU/L,
AP = 72 IU/L, g-GT = 115 IU/L, total bilirubin = 10
μmol/L, PTT = 90%, platelet count = 238 G/L. At dis-
charge from the intensive care unit (Day 36), the patient
remained O2 dependent (5 L/minute) with an arterial
blood gas demonstrating pH, PaCO2,a n dP a O 2 at 7, 42,
35 and 92 mmHg, respectively. The patient was dis-
charged from hospital at Day 48. Three months after
hospital discharge, the patient recovered a correct physi-
cal autonomy status without supplemental O2.
Discussion
This report describes the case of a patient with deep
hypoxaemia resulting from the combination of acute
respiratory distress and hepatopulmonary syndromes
and refractory to conventional mechanical ventilation
support. The life-threatening respiratory condition was
markedly improved by ECMO, allowing successful OLT.
To our knowledge, this is the first case report describing
the use of ECMO as a bridge to liver transplantation in
a cirrhotic patient with life-threatening hypoxaemia
resulting from combined ARDS and HPS.
Diagnosis of hepatopulmonary syndrome
HPS is defined as a triad of liver disease-induced portal
hypertension, increased alveolar-arterial gradient on
room air, and intrapulmonary vascular dilatation. The
latter is evidenced by contrast-enhanced echocardiogra-
phy detecting the presence of microbubbles injected
into an upper extremity vein within the left atrium
[4-6]. The overperfusion of normally aerated lung
regions reduces ventilation/perfusion ratios and causes
hypoxaemia. It can be moderate (PaO2 between 60 and
80 mmHg breathing room air) and well tolerated, or
severe (PaO2 ≤ 60 mmHg breathing room air), with pro-
gressive development of shortness of breath [6]. Platyp-
noea, defined by an increased dyspnoea when moving
from supine to upright position, and orthodoexia,
defined by a decrease in PaO2 > 5% or > 4 mmHg when
moving the patient from supine to upright position, are
characteristic features of HPS: both are related to
upright position-induced blood flow redistribution to
lung zones with prominent vascular dilatations, a phe-
nomenon resulting from the absence of pulmonary vas-
cular tone [16]. In our patient, hypoxaemia was not
diagnosed during the medical follow-up preceding OLT,
likely because hypoxaemia was moderate and well toler-
ated. At hospital admission, however, platypnoea was
present, raising the possibility of HPS, a hypothesis con-
firmed by a positive transthoracic contrast-enhanced
echocardiography.
Causes of the patient’s refractory hypoxaemia
The patient’s life-threatening and refractory hypoxaemia
was the result of three additive mechanisms: HPS,
ARDS and MV-induced lung hyperinflation. The
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lung aeration, affecting exclusively the lower lobes, and
an excess of inflammation predominating in the upper
lobes. Such a lung morphology, found in a majority of
patients meeting criteria for ARDS, is generally asso-
ciated with arterial hypoxaemia poorly responsive to
PEEP [11]. In our patient, HPS-induced vascular dilata-
tion predominantly found in nonaerated lower lobes
(Figure 1a), contributed to increase the pulmonary
shunt and rendered hypoxaemia totally refractory to
PEEP and inhaled nitric oxide.
In addition, focal lung morphology exposes patients to
MV-induced lung hyperinflation [11,17]. Despite the
reduction of TV to 6 ml/kg, lung hyperinflation is
observed in one-third of patients with acute respiratory
distress syndrome [18]. As observed in our patient, it
predominates initially in non-dependent and caudal lung
regions [19] and can lead to late air cysts and bronch-
iectasis in the same lung regions [20]. The immediate
effect of MV-induced hyperinflation is to redistribute
pulmonary regional blood flow away from upper lobes
towards non-aerated lower lobes, thereby further
increasing pulmonary shunt and worsening hypoxaemia.
The presence of HPS-induced vascular dilatation in
lower lobes is another aggravating factor explaining why
patient’s life-threatening hypoxaemia could be reversed
only by ECMO.
Treatment of hepatopulmonary syndrome
The medical options in the case of severe HPS-related
hypoxaemia are limited. Patients with severe hypoxae-
mia at rest should receive continuous long-term low-
flow oxygen therapy [6]. The benefit provided by Tren-
delenbourg positioning, insertion of a transjugular intra-
hepatic portosystemic shunt, embolisation or
pharmacological treatments, including inhaled nitric
oxide and nitric oxide inhibitors, have been reported but
never confirmed in larger studies [6]. Several studies
have demonstrated that HPS-induced severe hypoxaemia
can reverse after OLT [7,21,22]. According to the 2004
European Respiratory Society recommendations, the
indication of OLT is firm if PaO2 is between 50 and 60
mmHg but is discussed on an individual basis if PaO2 is
below 50 mmHg [6]. In our patient, hypervascularization
within lower lobes was not anymore visible on lung CT
performed 20 days after OLT, suggesting partial regres-
sion of HPS. Three months after OLT, the patient was
definitively weaned from nasal O2,s u g g e s t i n gt o t a l
reversal of HPS in a delay similar to what has been pre-
viously reported [23].
Indications of extracorporeal membrane oxygenation
ECMO may be deployed as arterio-venous ECMO pro-
viding both cardiac and respiratory support or as V-V
ECMO, which only provides oxygenation [2]. A recent
clinical report describes the case of a 12 year-old child
who, in the early post-operative period following OLT,
developed life-threatening hypoxaemia attributed to an
exacerbation of sepsis-induced ARDS by the existence
of a pre-transplantation HPS [8]. Facing the failure of
conventional MV combined with inhaled nitric oxide to
provide adequate control of oxygenation, the patient
was considered to be a candidate for V-V ECMO. He
remained 18 days on ECMO support, was successfully
weaned and remained well for longer than one year
post-transplantation. This report led us to consider that
ECMO could be a potential therapeutic option in our
patient and proposed as a bridge to liver transplantation.
It is unlikely that HPS alone, without concomitant loss
of lung aeration may justify ECMO. In fact, the combi-
nation of massive loss of lung aeration and HPS-induced
vascular dilatation in lower lobes with MV-induced
hyperinflation in upper lobes led to life-threatening
hypoxaemia refractory to any conventional treatment. In
our patient, ECMO could, via a better control of gas
exchange, lower the risk of hypoxaemia -related organ
failure during waiting time before OLT and during the
surgical procedure. Furthermore, ECMO initiated preo-
peratively could efficiently prevent HPS-related worsen-
ing of postoperative hypoxaemia.
Beside its potential benefits, ECMO may have some
harmful effects. The use of an extracorporeal circuit,
requiring systemic anticoagulation, and often leading to
thrombocytopenia carries a potential risk of bleeding
complications, especially in a cirrhotic patient who may
already have thrombocytopenia and compromised liver
function tests. Moreover, a higher incidence of infec-
tious complications related to the intravascular insertion
of the ECMO cannulae can be dreaded in a cirrhotic
patient. More data concerning the safety issues asso-
ciated with the use of ECMO in patients with HPS are,
therefore, needed.
Conclusions
In conclusion, we report the case of a patient with
ARDS, aggravated by HPS and MV-induced hyperinfla-
tion, responsible for life-threatening hypoxaemia not
controlled by standard supportive measures. The use of
ECMO, by controlling gas exchange, allowed the per-
forming of successful OLT. These preliminary data,
therefore, suggest that ECMO could have a place in
patients eligible for OLT. It provides the basis to test
this strategy in a larger number of patients presenting a
combination of acute parenchymal disease and HPS.
Key messages
￿ Our report suggests that ECMO could have a place
as a bridge to liver transplantation in patients
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ease and hepatopulmonary syndrome
￿ It provides the basis to test this strategy in a larger
number of patients
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